The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Problems in the “Evidence” of “Evidence-Based Medicine”
Open accessAbstract
The proposed practice of "evidence-based medicine," which calls for careful clinical judgment in evaluating the "best available evidence," should be differentiated from the special collection of data regarded as suitable evidence. Although the proposed practice does not seem new, the new collection of "best available" information has major constraints for the care of individual patients. Derived almost exclusively from randomized trials and meta-analyses, the data do not include many types of treatments or patients seen in clinical practice; and the results show comparative efficacy of treatment for an "average" randomized patient, not for pertinent subgroups formed by such cogent clinical features as severity of symptoms, illness, co-morbidity, and other clinical nuances. The intention-to-treat analyses do not reflect important post-randomization events leading to altered treatment; and the results seldom provide suitable background data when therapy is given prophylactically rather than remedially, or when therapeutic advantages are equivocal. Randomized trial information is also seldom available for issues in etiology, diagnosis, and prognosis, and for clinical decisions that depend on pathophysiologic changes, psychosocial factors and support, personal preferences of patients, and strategies for giving comfort and reassurance. The laudable goal of making clinical decisions based on evidence can be impaired by the restricted quality and scope of what is collected as "best available evidence." The authoritative aura given to the collection, however, may lead to major abuses that produce inappropriate guidelines or doctrinaire dogmas for clinical practice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the likelihood of response of these syndromes to the introduction of new antidepressants is very variable [29-33].”
From The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem (2020) · cites this paper as [31]
In the citing paper
“Even with slow tapering, the likelihood of withdrawal syndromes and persistent postwithdrawal disorders and symptoms is very high”
From The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem (2020) · cites this paper as [31]
Citations
Cites
Evidence based medicine: what it is and what it isn't
Sackett, D. L., Rosenberg, W. M. C., Gray, J. A. M., Haynes, R. B., & Richardson, W. S. (1996) · BMJ · doi:10.1136/bmj.312.7023.71 · Cited by 15,769
Evidence-Based Medicine: A New Approach to Teaching the Practice of Medicine
Guyatt, G. (1992) · JAMA · doi:10.1001/jama.1992.03490170092032 · Cited by 4,202
Effective Care in Pregnancy and Childbirth
Paintin, D. B. (1990) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1990.tb02464.x · Cited by 1,330
The Effects of Antihypertensive Therapy on the Quality of Life
Croog, S. H., Levine, S., Testa, M. A., Brown, B., Bulpitt, C. J., Jenkins, C. D., Klerman, G. L., & Williams, G. H. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606263142602 · Cited by 1,325
Moher, D., Jadad, A. R., Nichol, G., Penman, M., Tugwell, P., & Walsh, S. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)00031-w · Cited by 1,308
Meta-Analyses of Randomized Controlled Trials
Sacks, H. S., Berrier, J., Reitman, D., Ancona-Berk, V. A., & Chalmers, T. C. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702193160806 · Cited by 1,250
Bero, L. (1995) · JAMA · doi:10.1001/jama.1995.03530240045039 · Cited by 714
Use of methodological standards in diagnostic test research. Getting better but still not good
Reid, M. C. (1995) · JAMA · doi:10.1001/jama.274.8.645 · Cited by 712
Grey zones of clinical practice: some limits to evidence-based medicine
Naylor, C. D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92969-x · Cited by 663
Incorporating variations in the quality of individual randomized trials into meta-analysis
Detsky, A. S., Naylor, C. D., O'Rourke, K., McGeer, A. J., & L'Abbé, K. A. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90085-2 · Cited by 640
Research works printed but not linked: 3
- Reid, 1995, Use of methodological standards in diagnostic test research, JAMA., 274, 645, 10.1001/jama.1995.03530080061042 · doi:10.1001/jama.1995.03530080061042 · Paper page
- Dudley L. Update on the Cochrane Collaboration. In Clinical Epidemiology Newsletter. 1994;14:2–3. (Dept. of Clin. Epid. and Biostat., McMaster Univ.)
- Haynes, 1994, News from the Canadian Cochrane network and centre, Clinical Epidemiology Newsletter., 14, 3
Cited by
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17670-8 · Cited by 2,544
Interpretation of the evidence for the efficacy and safety of statin therapy
Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Blumenthal, R., Danesh, J., Smith, G. D., DeMets, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31357-5 · Cited by 1,857
Understanding and misunderstanding randomized controlled trials
Deaton, A., & Cartwright, N. (2018) · Social Science & Medicine · doi:10.1016/j.socscimed.2017.12.005 · Cited by 1,841
Current methods of the U.S. Preventive Services Task Force
Harris, R. P., Helfand, M., Woolf, S. H., Lohr, K. N., Mulrow, C. D., Teutsch, S. M., & Atkins, D. (2001) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(01)00261-6 · Cited by 1,731
“A well-designed cohort study may be more compelling than an inadequately powered or poorly conducted RCT.(21,22)”
MethodToward Evidence-Based Medical Statistics. 1: The P Value Fallacy
Goodman, S. N. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-12-199906150-00008 · Cited by 1,185
Metadata
- Authors
- Feinstein, A. R., & Horwitz, R. I.
- Affiliations
- Yale University (US)
- ORCID
- Horwitz, Ralph I
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 1997-12
- Volume
- 103
- Issue
- 6
- Pages
- 529-535
- ISSN
- 0002-9343 (ISSN-L)
- OpenAlex
- W2034401866
- Cited by
- 653
- References
- 33
- Citations by year
- 2026: 15 · 2025: 9 · 2024: 12 · 2023: 13 · 2022: 21 · 2021: 8 · 2020: 36 · 2019: 18 · 2018: 24 · 2017: 24 · 2016: 15 · 2015: 23 · 2014: 26 · 2013: 27 · 2012: 21
- FWCI
- 32.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 1003 d)
- Locations
- The American Journal of Medicine (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Health Sciences › Health Professions › General Health Professions › Health Sciences Research and Education
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Keywords
- evidence-based medicine, meta-analysis, subgroup analysis, intention-to-treat analysis, prophylaxis, clinical judgment, quality of evidence, individual patient care
- MeSH terms
- Decision Making, Humans, Risk Factors, Randomized Controlled Trials as Topic, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Problems in the “Evidence” of “Evidence-Based Medicine”. https://app.cochat.ai/papers/10.1016/s0002-9343(97)00244-1
- The paper
- Feinstein, A. R., & Horwitz, R. I. (1997). Problems in the “Evidence” of “Evidence-Based Medicine”. The American Journal of Medicine. https://doi.org/10.1016/s0002-9343(97)00244-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.